Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Other ORP type
Data sources: ZENODO
Zenodo
Claim

What are the latest advancements in the management and treatment of arteriosclerosis discussed in the May-June issue of 'Clínica e Investigación en Arteriosclerosis'?

descriptionPublicationkeyboard_double_arrow_right Other ORP type Under curationPublisher:Zenodo
Authors: Tripdatabase;

doi: 10.5281/zenodo.20564487

What are the latest advancements in the management and treatment of arteriosclerosis discussed in the May-June issue of 'Clínica e Investigación en Arteriosclerosis'?

Abstract

Recent studies highlight novel approaches to managing arteriosclerosis, including nanoparticle drug delivery, stem cell therapy, advancements in procedural strategies for arteriosclerosis obliterans, and the role of remnant cholesterol in residual cardiovascular risk.

Powered by OpenAIRE graph
Found an issue? Give us feedback